Literature DB >> 16083258

Proteomics in the forefront of cancer biomarker discovery.

Sudhir Srivastava1, Rashmi-Gopal Srivastava.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16083258     DOI： 10.1021/pr050016u

Source DB:  PubMed          Journal:  J Proteome Res        ISSN： 1535-3893            Impact factor:   4.466


× No keyword cloud information.
  9 in total

1.  Challenges and solutions in proteomics.

Authors:  Huang Hongzhan; Hem D Shukla; Wu Cathy; Saxena Satya
Journal:  Curr Genomics       Date:  2007-03       Impact factor: 2.236

2.  An insight into high-resolution mass-spectrometry data.

Authors:  J E Eckel-Passow; A L Oberg; T M Therneau; H R Bergen
Journal:  Biostatistics       Date:  2009-03-26       Impact factor: 5.899

3.  Serum cytokeratin 18 as a biomarker for gastric cancer.

Authors:  Katsunobu Oyama; Sachio Fushida; Jun Kinoshita; Koichi Okamoto; Isamu Makino; Keishi Nakamura; Hironori Hayashi; Masafumi Inokuchi; Hisatoshi Nakagawara; Hidehiro Tajima; Hideto Fujita; Hiroyuki Takamura; Itasu Ninomiya; Hirohisa Kitagawa; Takashi Fujimura; Tetsuo Ohta
Journal:  Clin Exp Med       Date:  2012-07-24       Impact factor: 3.984

4.  Differential Plasma Glycoproteome of p19 Skin Cancer Mouse Model Using the Corra Label-Free LC-MS Proteomics Platform.

Authors:  Simon Letarte; Mi-Youn Brusniak; David Campbell; James Eddes; Christopher J Kemp; Hollis Lau; Lukas Mueller; Alexander Schmidt; Paul Shannon; Karen S Kelly-Spratt; Olga Vitek; Hui Zhang; Ruedi Aebersold; Julian D Watts
Journal:  Clin Proteomics       Date:  2008-12-01       Impact factor: 3.988

5.  Spatiotemporal proteomic analyses during pancreas cancer progression identifies serine/threonine stress kinase 4 (STK4) as a novel candidate biomarker for early stage disease.

Authors:  Justin E Mirus; Yuzheng Zhang; Michael A Hollingsworth; Joell L Solan; Paul D Lampe; Sunil R Hingorani
Journal:  Mol Cell Proteomics       Date:  2014-09-15       Impact factor: 5.911

Review 6.  High-throughput genomic technology in research and clinical management of breast cancer. Plasma-based proteomics in early detection and therapy.

Authors:  Michael A Davis; Samir Hanash
Journal:  Breast Cancer Res       Date:  2006       Impact factor: 6.466

7.  Identification of GlcNAcylated alpha-1-antichymotrypsin as an early biomarker in human non-small-cell lung cancer by quantitative proteomic analysis with two lectins.

Authors:  Yanxia Jin; Jie Wang; Xiangdong Ye; Yanting Su; Guojun Yu; Qing Yang; Wei Liu; Wenhui Yu; Jie Cai; Xi Chen; Yi Liang; Yijie Chen; Barry Hon Cheung Wong; Xiangning Fu; Hui Sun
Journal:  Br J Cancer       Date:  2016-02-23       Impact factor: 7.640

8.  Cytokeratin 18 in plasma of patients with gastrointestinal adenocarcinoma as a biomarker of tumour response.

Authors:  L C Scott; T R J Evans; J Cassidy; S Harden; J Paul; R Ullah; V O'Brien; R Brown
Journal:  Br J Cancer       Date:  2009-07-14       Impact factor: 7.640

Review 9.  Challenges and Opportunities in Clinical Applications of Blood-Based Proteomics in Cancer.

Authors:  Ruchika Bhawal; Ann L Oberg; Sheng Zhang; Manish Kohli
Journal:  Cancers (Basel)       Date:  2020-08-27       Impact factor: 6.639
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.